Skip to main content

Abstract

Herpes simplex virus type 1 (HSV-1) is among the most common human pathogens worldwide. Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are responsible for orofacial and genital herpes, respectively. In the majority of cases, orofacial HSV infections are caused by HSV-1, but HSV-2 have also been reported in sexually active persons and in HIV patients. Transmission takes place through direct contact with skin lesions, mucous membranes, and secretions (i.e., saliva). Transmission of HSV can occur during both asymptomatic and symptomatic periods of viral shedding. The most common clinical presentation of primary HSV-1 infection is gingivostomatitis in children and young adults. The clinical symptoms of the recurrent infection start with a group of vesicles on an erythematous base, most commonly at the mucocutaneous junction of the lips. Treatment regimens differ from symptomatic and topical antivirals to oral antivirals or suppressive schedules, depending on the severity, the immune status, and the characteristics of the infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Anthony R, Hodge V, Field HJ. Antiviral agents for herpes simplex virus. Adv Pharmacol. 2013;67:1–35.

    Article  Google Scholar 

  • Antoine TE, Park PJ, Shukla D. Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics. Rev Med Virol. 2013;23:194–208.

    Article  CAS  Google Scholar 

  • Bolognia JL, Jorizzo JL, Rapini RP. Dermatology (Mosby Publications). Hum Herpesviruses. 2003;1(80):1235–40.

    Google Scholar 

  • Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008;168:1137–44.

    Article  CAS  Google Scholar 

  • Hadigal S, Shukla D. Exploiting herpes simplex virus entry for novel therapeutics. Viruses. 2013;5:1447–65.

    Article  Google Scholar 

  • Spear PG, Longnecker R. Herpesvirus entry: an update. J Virol. 2003;77:10179–85.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Theognosia Vergou .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Vergou, T. (2015). Herpes Simplex Virus Infection (Orofacial). In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45139-7_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45138-0

  • Online ISBN: 978-3-662-45139-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics